Sanofi and Regeneron are throwing an already-approved drug at COVID-19, testing Kevzara (sarilumab) in patients hospitalised with severe disease. The thinking behind this trial is similar to that ...

Last December, the terms of the partnership on Kevzara and Praluent were reworked, with Regeneron getting US rights to the cholesterol drug while Sanofi claimed global rights to Kevzara in a move ...

Regeneron Pharmaceuticals ... REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused ...

Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...

Yancopoulos, M.D., Ph.D., Board Co-Chair, President and Chief Scientific Officer at Regeneron. “These early insights from the COURAGE trial are consistent with recently published pre-clinical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WASHINGTON, DC – Achyuta Rajaram, 17, of Exeter, NH, has been named the winner of won the top award in the Regeneron Science Talent Sea Achyuta Rajaram 2024, America’s oldest and most ...

LOS ANGELES, CA – Regeneron Pharmaceuticals, Inc. and the Society for Science on May 17 announced that Krish Pai, 17, of Del Mar, California, received the second Regeneron Young Scientist Award ...